Researchers modify T cells to treat recurrent leukemia

02/28/2013 | DailyRx.com

The infusion of T cells programmed to detect a tumor antigen and exposed to interleukin 21 appeared to extend survival for patients with recurrent leukemia who had received stem cell transplants. The results of the small study were published in the journal Science Translational Medicine.

View Full Article in:

DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA